Chagas Disease: Implementation of Screening to Benefit Mother and Infant

Morven S Edwards; Susan P Montgomery

doi:10.1016/j.clp.2021.03.013

Chagas Disease: Implementation of Screening to Benefit Mother and Infant

Clin Perinatol. 2021 Jun;48(2):331-342. doi: 10.1016/j.clp.2021.03.013.

Authors

Morven S Edwards¹, Susan P Montgomery²

Affiliations

¹ Texas Children's Hospital, Feigin Center, 1102 Bates Avenue, Suite 1120, Houston, TX 77030, USA. Electronic address: morvene@bcm.edu.
² Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Center Global Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Northeast, Atlanta, GA 30333, USA.

Abstract

Pregnancy-based screening would identify women with Chagas disease, allowing for treatment of Trypanosoma cruzi-infected women and infants to prevent potentially fatal Chagas cardiomyopathy.

Keywords: Cardiomyopathy; Chagas disease; Congenital infection; Serologic screening; Trypanosoma cruzi.

Publication types

Review

MeSH terms

Chagas Disease* / diagnosis
Chagas Disease* / drug therapy
Chagas Disease* / epidemiology
Female
Humans
Infant
Infectious Disease Transmission, Vertical / prevention & control
Mothers
Pregnancy
Pregnancy Complications, Parasitic* / diagnosis
Trypanosoma cruzi*

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States